$Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus$

Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus

Bibliographic Details
Main Authors:	Warner Robinson, DDS, Beth N. McLellan, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	JAAD Case Reports
Subjects:	checkpoint inhibitor dupilumab Dupixent PD-1 inhibitor vitiligo
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512623003533

Internet